The Analyst Verdict: Tenet Healthcare In The Eyes Of 12 Experts

Over the past three months, 12 analysts have provided diverse ratings for Tenet Healthcare (NYSE: THC), with 6 bullish and 6 somewhat bullish assessments. The average price target has increased to $259.25, up 5.28% from the previous average of $246.25, with a high estimate of $288.00 and a low of $229.00. The article also highlights Tenet Healthcare’s strong financial health, including impressive net margin, return on equity, and return on assets, despite a high debt-to-equity ratio.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
  • Pin

Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate App
Community
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)